Insiders Updates Potential Price Increase for Plus Therapeutics Inc (PSTV) After Recent Insider Activity Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22
Analysts Viewpoint Plus Therapeutics Inc [PSTV] Investment Guide: What You Need to Know Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Featured Plus Therapeutics, Inc. (PTSC) Stock Price on the Rise as RNL Gains Traction Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing